Procarbazine

ATC Code L01XB01

Procarbazine

Definition

A methylhydrazine derivative with antineoplastic and mutagenic activities. Although the exact mode of cytotoxicity has not been elucidated, procarbazine, after metabolic activation, appears to inhibit the trans-methylation of methionine into transfer RNA (t-RNA), thereby preventing protein synthesis and consequently DNA and RNA synthesis. This agent may also undergo auto-oxidation, resulting in the formation of cytotoxic free radicals which damage DNA through an alkylation reaction.

Also known as Benzethyzin, Ibenzmethyzin, N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]benzamide, N-4-isopropylcarbamoylbenzyl-N'-methylhydrazine, N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide, N-Methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide, Procarbazin, PROCARBAZINE — per NCIT

Also identified as

Indications

Disease Relation Source
Brain cancer may treat MEDRT · Public domain (U.S. Government work)
Hodgkins lymphoma may treat MEDRT · Public domain (U.S. Government work)
Lung neoplasm may treat MEDRT · Public domain (U.S. Government work)
Melanoma may treat MEDRT · Public domain (U.S. Government work)
Multiple myeloma may treat MEDRT · Public domain (U.S. Government work)
Non-Hodgkin lymphoma may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Lymphoid system may treat a disease of this organ DERIVED · CC BY 4.0

1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.